• SEPTEMBER 12, 2025
    • 0
    JOIN WITH US !

    JOIN WITH US !

    The Indonesia Research Partnership on Infectious Diseases (INA-RESPOND) is opening recruitment for several strategic positions. This is an exciting opportunity to join a collaborative, sustainable, and internationally recognized clinical research network that plays a key role in addressing infectious disease challenges in Indonesia and contributing to the global health research agenda. INA-RESPOND works with PT.Read more
    • JULY 31, 2025
    • 0

    Bridging The Gaps in Hepatitis B Vaccination in Indonesia:From Childhood Coverage to Adult Willingness

    By: Cintya Naya Danastri, Ivana Yulian, Putri Permata Sari What’s this about? World Hepatitis Day, observed every year on July 28, is one of the World Health Organization’s (WHO) nine officially designated global public health days. It serves as a global call to action to raise awareness about the burden of viral hepatitis and to

    Read more
    • JULY 31, 2025
    • 0

    Ensuring Clinical Trial Readiness through a Comprehensive Site Initiation Visit and Site Management During Ongoing Clinical Trial

    By: INA-RESPOND CRA and CRSS Site readiness is a cornerstone of successful clinical trial execution. The journey from site activation to ongoing trial management requires careful planning, clear communication, and continuous oversight. One of the most critical steps in this process is the Site Initiation Visit (SIV), which serves as the official launch of site

    Read more
    • JUNE 19, 2025
    • 0

    Regulatory, Ethics, MTA Submission

    By: INA-RESPOND CRSS Introduction In Indonesia, the conduct of clinical trials in compliance with Good Clinical Practice (GCP) is regulated and overseen by several authorities. These include the Institutional Review Board (IRB)/Independent Ethics Committee (IEC), which safeguards the rights and well-being of trial participants; the National Agency of Drug and Food Control/ Badan Pengawas ObatRead more